Will NCT06736041 (Sanofi Pasteur, a Sanofi Company) still show a study completion date of 17 May 2027 or earlier when checked on 16 June 2027?
deadline 2027-06-16
confidence medium
tier 4 evidence
65%PolySignal estimate
Resolution criterion
Yes if, when NCT06736041 is read on clinicaltrials.gov on 16 June 2027, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 17 May 2027 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 2 October 2026: NCT06736041 is registered as ACTIVE_NOT_RECRUITING, sponsored by Sanofi Pasteur, a Sanofi Company, with 1714 participants. Started 2024-12; announced primary completion 2027-05-17, announced study completion 2027-05-17. Record last updated 2026-04-22. The date under test is 2027-05-17. Source: clinicaltrials.gov/study/NCT06736041
What pushes it up
- The trial is already registered as 'ACTIVE_NOT_RECRUITING', meaning recruitment is completed, which eliminates the primary source of clinical trial delays [1].
- The sponsor is Sanofi Pasteur, a major pharmaceutical company with the resources and experience to manage trial timelines effectively [1].
What pushes it down
- Clinical trials are inherently prone to follow-up, data collection, or administrative delays that can lead to pushing back the completion date [1].
- The evaluation date (16 June 2027) is only one month after the scheduled completion date (17 May 2027), leaving very little buffer for any minor delays [1].
What would move this number most
Whether any follow-up or data collection issues arise during the remaining course of the trial that would force Sanofi to extend the study completion date.
How this number is built
| Deadline | 2027-06-16 |
| Base rate | 65% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 48 · 65 · 65 (spread 17 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-02 07:38 |
| Model | gemini-3.5-flash |